BOOSTING BRAIN PROTEIN COULD SLOW ALZHEIMER’S DISEASE

Mario Nawfal
@MarioNawfal
🚨BOOSTING BRAIN PROTEIN COULD SLOW ALZHEIMER’S DISEASE

A study from the University of Cincinnati suggests that increasing amyloid-beta 42 (Aβ42) levels in the brain could slow the disease’s progression.

New treatments like lecanemab and donanemab, which raise Aβ42 levels, have been linked to slower cognitive decline.

The research, based on data from 26,000 patients, proposes focusing on boosting Aβ42 rather than targeting amyloid plaques.

Source: Fox News